Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$106.90 USD
-4.13 (-3.72%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $106.11 -0.79 (-0.74%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MLAB 106.90 -4.13(-3.72%)
Will MLAB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLAB
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
MLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Value Stocks to Buy for April 8th
Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates
Reasons to Add Integer Holdings (ITGR) to Your Portfolio Now
Other News for MLAB
Mesa Labs Announces First Quarter Results
Mesa Labs reports Q1 EPS 62c, consensus 44c
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Labs price target lowered by $10 at Evercore ISI, here's why
MLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024